Workflow
大参林一实控人拟减持2%股份 曾因单位行贿罪一审获刑三年半

Core Viewpoint - The actual controller of Dazhenglin, Ke Jinlong, plans to reduce his holdings by up to 22.777 million shares, accounting for 2% of the total share capital, aiming to raise approximately 394 million yuan [1][3]. Group 1: Share Reduction Plan - The share reduction plan will officially start on June 27 and continue until September 26 [3]. - Dazhenglin stated that the purpose of this reduction is to adjust asset and financing structure, repay personal debts, and lower the stock pledge ratio [3]. - Ke Jinlong currently holds a 20.16% stake, making him the second-largest shareholder [3]. Group 2: Legal Issues and Penalties - Dazhenglin's wholly-owned subsidiary, Maoming Dazhenglin Chain Pharmacy, was fined 4 million yuan for unit bribery, while Ke Jinlong received a three-and-a-half-year prison sentence and a fine of 500,000 yuan for the same offense [3]. - The case originated from the subsidiary's historical wholesale business, with involved customer sales accounting for 0.25%, 0.20%, and 0.15% of total revenue from 2020 to 2022 [3]. - Ke Jinlong was placed under detention on July 14, 2023, and criminally detained on August 21, but Dazhenglin did not disclose this until March 1, 2024 [3]. Group 3: Regulatory Actions - The Guangdong Securities Regulatory Bureau took regulatory measures against Dazhenglin and related responsible persons [3]. - The Shanghai Stock Exchange imposed a six-month suspension on accepting issuance applications and publicly reprimanded the actual controllers, including Ke Jinlong [3]. - Ke Jinlong, along with his brothers, collectively controls 64.04% of the shares, forming a concerted action relationship [3].